Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

Two drugs commonly known as Mounjaro and Trulicity, will not be available for online sale to non-Canadian residents.

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...

A woman has shared some key ‘warning signs’ that suggest you might be using Mounjaro wrong. Aesthetics practitioner Annabelle Welch has spoken about the changes she has noticed in her clients at her ...

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...

Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...